Stocktoria

Astrana Health, Inc. ASTH

Nasdaq · stock · Services-Management Consulting Services · website · IPO 1999-04-09

Astrana Health, Inc. statistics & valuation

Market cap$2.2B
P / E98.1×
P / S0.7×
P / B2.8×
P / FCF21.1×
Dividend yield0.36%
Net margin0.7%
Return on equity2.8%
FCF margin3.3%
Net debt$561.4M
Net debt / EBITDA4.5×
Enterprise value USD$2.8B
EV / EBITDA22.3×
Earnings yield EBIT/EV2.8%
Return on capital4.9%
Graham number -64%$12.90

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($12.90); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
-15.60% 7.20% 2.10% 2.50% 5.50% 8.90% 3.90% 4.40% 2.10% 0.70% 2017201720182019202020212022202320242025
Gross margin (%)
2017201720182019202020212022202320242025
Operating margin (%)
-18.30% 9.80% 17.00% 5.80% 11.70% 12.70% 9.10% 6.10% 4.40% 2.50% 2017201720182019202020212022202320242025
Return on equity (%)
15.70% 6.00% 7.30% 11.40% 15.20% 8.30% 9.80% 6.00% 2.80% 2017201720182019202020212022202320242025
Shares outstanding
6.0M 32.3M 37.9M 36.4M 42.2M 45.4M 46.6M 46.9M 48.0M 49.4M 2017201720182019202020212022202320242025
Net debt ($)
-$106.9M $129.0M $36.7M -$50.2M -$84.6M -$34.9M $136.8M $561.4M 2017201720182019202020212022202320242025
Share buybacks ($)
2017201720182019202020212022202320242025
Return on assets (%)
-43.40% 5.30% 2.10% 1.90% 4.60% 8.10% 4.70% 6.50% 3.20% 1.00% 2017201720182019202020212022202320242025
Free cash flow margin (%)
-14.70% 13.90% 4.70% 2.30% 6.50% 6.60% 5.20% 2.90% 2.20% 3.30% 2017201720182019202020212022202320242025
Debt / equity (×)
0.00× 1.21× 0.70× 0.40× 0.37× 0.42× 0.59× 1.25× 2017201720182019202020212022202320242025
EPS ($)
$0.90 $0.29 $0.39 $1.01 $1.52 $0.99 $1.29 $0.90 $0.46 2017201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

Astrana Health, Inc. trades at about 77.8× earnings — above its 10-year norm (10-year range 20.3×–67.3×, median 36×).

20.3× 77.8×

Shaded band = 10-year range (20.3×–67.3×); dot = today's 77.8×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2017
Operating margin2.5%4.4%6.1%9.1%12.7%11.7%5.8%17.0%9.8%-18.3%
Net margin0.7%2.1%4.4%3.9%8.9%5.5%2.5%2.1%7.2%-15.6%
FCF margin3.3%2.2%2.9%5.2%6.6%6.5%2.3%4.7%13.9%-14.7%
Return on assets1.0%3.2%6.5%4.7%8.1%4.6%1.9%2.1%5.3%-43.4%
Return on equity2.8%6.0%9.8%8.3%15.2%11.4%7.3%6.0%15.7%2534.7%
Debt / equity1.25×0.59×0.42×0.37×0.40×0.70×1.21×0.00×——
Current ratio1.401.752.112.883.462.943.122.401.321.03

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.